MacroGenics (MGNX)
NASDAQ:MGNX
Want to see MGNX full AI Analyst Report?
Total Valuation
MacroGenics has a market cap or net worth of $270.14M. The enterprise value is $240.14M.
Market Cap$270.14M
Enterprise Value$240.14M
Share Statistics
MacroGenics has 63,563,120 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding63,563,120
Owned by Insiders2.53%
Owned by Institutions21.47%
Financial Efficiency
MacroGenics’s return on equity (ROE) is -1.34 and return on invested capital (ROIC) is -32.98%.
Return on Equity (ROE)-1.34
Return on Assets (ROA)-0.29
Return on Invested Capital (ROIC)-32.98%
Return on Capital Employed (ROCE)-0.34
Revenue Per Employee438.42K
Profits Per Employee-218.83K
Employee Count341
Asset Turnover0.58
Inventory Turnover5.46
Valuation Ratios
The current PE Ratio of MacroGenics is ―. MacroGenics’s PEG ratio is -0.13.
PE Ratio―
PS Ratio0.68
PB Ratio1.83
Price to Fair Value1.83
Price to FCF-1.23
Price to Operating Cash Flow-3.85
PEG Ratio-0.13
Income Statement
In the last 12 months, MacroGenics had revenue of 149.50M and earned -74.62M in profits. Earnings per share was -1.18.
Revenue149.50M
Gross Profit106.32M
Operating Income-72.84M
Pretax Income-75.29M
Net Income-74.62M
EBITDA-65.67M
Earnings Per Share (EPS)-1.18
Cash Flow
In the last 12 months, operating cash flow was -69.96M and capital expenditures -1.73M, giving a free cash flow of -71.69M billion.
Operating Cash Flow-69.96M
Free Cash Flow-71.69M
Free Cash Flow per Share-1.13
Dividends & Yields
MacroGenics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.12
52-Week Price Change167.30%
50-Day Moving Average2.59
200-Day Moving Average1.87
Relative Strength Index (RSI)63.11
Average Volume (3m)1.40M
Important Dates
MacroGenics upcoming earnings date is Aug 11, 2026, TBA (Confirmed).
Last Earnings DateMay 13, 2026
Next Earnings DateAug 11, 2026
Ex-Dividend Date―
Financial Position
MacroGenics as a current ratio of 5.10, with Debt / Equity ratio of 172.23%
Current Ratio5.10
Quick Ratio4.92
Debt to Market Cap0.74
Net Debt to EBITDA-0.75
Interest Coverage Ratio-8.56
Taxes
In the past 12 months, MacroGenics has paid -672.00K in taxes.
Income Tax-672.00K
Effective Tax Rate<0.01
Enterprise Valuation
MacroGenics EV to EBITDA ratio is -2.30, with an EV/FCF ratio of -1.82.
EV to Sales1.01
EV to EBITDA-2.30
EV to Free Cash Flow-1.82
EV to Operating Cash Flow-1.87
Balance Sheet
MacroGenics has $154.23M in cash and marketable securities with $36.51M in debt, giving a net cash position of $117.72M billion.
Cash & Marketable Securities$154.23M
Total Debt$36.51M
Net Cash$117.72M
Net Cash Per Share$1.85
Tangible Book Value Per Share$0.88
Margins
Gross margin is 69.93%, with operating margin of -48.72%, and net profit margin of -49.91%.
Gross Margin69.93%
Operating Margin-48.72%
Pretax Margin-50.36%
Net Profit Margin-49.91%
EBITDA Margin-43.93%
EBIT Margin-48.72%
Analyst Forecast
The average price target for MacroGenics is $6.33, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.33
Price Target Upside83.04% Upside
Analyst ConsensusModerate Buy
Analyst Count5
Revenue Growth Forecast1.97%
EPS Growth Forecast-25.03%